Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment

S. G. Berrak, C. Canpolat, P. Berik, G. Kiyan

Research output: Contribution to journalArticle

Abstract

The usefulness of L-asparaginase as a chemotherapeutic agent has been established for the treatment of various lymphoproliferative disorders including acute lymphoblastic leukemia and lymphoma. Pancreatitis is well recognized as a potential complication in 2% to 16% of patients undergoing treatment with L-asparaginase and the reported cases have usually been self-limited. Less well appreciated is the progression of such pancreatitis in some patients to pseudocyst formation which may sometimes necessitate surgical intervention. Only nine cases of pancreatic pseudocyst secondary to L-asparaginase have been reported so far. Eight of nine reported cases of pancreatic pseudocyst required surgical intervention. Our patient is the second case in whom non-surgical management was sufficient.

Original languageEnglish (US)
Pages (from-to)413-416
Number of pages4
JournalInternational Journal of Pediatric Hematology/Oncology
Volume7
Issue number5-6
StatePublished - 2001
Externally publishedYes

Fingerprint

Pancreatic Pseudocyst
Asparaginase
Pancreatitis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoproliferative Disorders
Therapeutics

Keywords

  • Acute pancreatitis
  • L-asparaginase
  • Pancreatic pseudocyst

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Pediatrics, Perinatology, and Child Health

Cite this

Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment. / Berrak, S. G.; Canpolat, C.; Berik, P.; Kiyan, G.

In: International Journal of Pediatric Hematology/Oncology, Vol. 7, No. 5-6, 2001, p. 413-416.

Research output: Contribution to journalArticle

Berrak, S. G. ; Canpolat, C. ; Berik, P. ; Kiyan, G. / Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment. In: International Journal of Pediatric Hematology/Oncology. 2001 ; Vol. 7, No. 5-6. pp. 413-416.
@article{1ecae53a66284e0885bcebe14eea28d5,
title = "Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment",
abstract = "The usefulness of L-asparaginase as a chemotherapeutic agent has been established for the treatment of various lymphoproliferative disorders including acute lymphoblastic leukemia and lymphoma. Pancreatitis is well recognized as a potential complication in 2{\%} to 16{\%} of patients undergoing treatment with L-asparaginase and the reported cases have usually been self-limited. Less well appreciated is the progression of such pancreatitis in some patients to pseudocyst formation which may sometimes necessitate surgical intervention. Only nine cases of pancreatic pseudocyst secondary to L-asparaginase have been reported so far. Eight of nine reported cases of pancreatic pseudocyst required surgical intervention. Our patient is the second case in whom non-surgical management was sufficient.",
keywords = "Acute pancreatitis, L-asparaginase, Pancreatic pseudocyst",
author = "Berrak, {S. G.} and C. Canpolat and P. Berik and G. Kiyan",
year = "2001",
language = "English (US)",
volume = "7",
pages = "413--416",
journal = "International Journal of Pediatric Hematology/Oncology",
issn = "1070-2903",
publisher = "Taylor and Francis Ltd.",
number = "5-6",

}

TY - JOUR

T1 - Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment

AU - Berrak, S. G.

AU - Canpolat, C.

AU - Berik, P.

AU - Kiyan, G.

PY - 2001

Y1 - 2001

N2 - The usefulness of L-asparaginase as a chemotherapeutic agent has been established for the treatment of various lymphoproliferative disorders including acute lymphoblastic leukemia and lymphoma. Pancreatitis is well recognized as a potential complication in 2% to 16% of patients undergoing treatment with L-asparaginase and the reported cases have usually been self-limited. Less well appreciated is the progression of such pancreatitis in some patients to pseudocyst formation which may sometimes necessitate surgical intervention. Only nine cases of pancreatic pseudocyst secondary to L-asparaginase have been reported so far. Eight of nine reported cases of pancreatic pseudocyst required surgical intervention. Our patient is the second case in whom non-surgical management was sufficient.

AB - The usefulness of L-asparaginase as a chemotherapeutic agent has been established for the treatment of various lymphoproliferative disorders including acute lymphoblastic leukemia and lymphoma. Pancreatitis is well recognized as a potential complication in 2% to 16% of patients undergoing treatment with L-asparaginase and the reported cases have usually been self-limited. Less well appreciated is the progression of such pancreatitis in some patients to pseudocyst formation which may sometimes necessitate surgical intervention. Only nine cases of pancreatic pseudocyst secondary to L-asparaginase have been reported so far. Eight of nine reported cases of pancreatic pseudocyst required surgical intervention. Our patient is the second case in whom non-surgical management was sufficient.

KW - Acute pancreatitis

KW - L-asparaginase

KW - Pancreatic pseudocyst

UR - http://www.scopus.com/inward/record.url?scp=0035679435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035679435&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035679435

VL - 7

SP - 413

EP - 416

JO - International Journal of Pediatric Hematology/Oncology

JF - International Journal of Pediatric Hematology/Oncology

SN - 1070-2903

IS - 5-6

ER -